 Alisha Chitrakar
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interferons | 2 | 2021 | 186 | 1.150 |
Why?
| | Blood Donors | 2 | 2025 | 144 | 0.940 |
Why?
| | Blood Platelets | 3 | 2025 | 379 | 0.870 |
Why?
| | Blood Preservation | 3 | 2025 | 346 | 0.820 |
Why?
| | Hormone Replacement Therapy | 1 | 2024 | 107 | 0.770 |
Why?
| | Endoribonucleases | 3 | 2019 | 77 | 0.760 |
Why?
| | DEAD Box Protein 58 | 1 | 2021 | 7 | 0.710 |
Why?
| | RNA, Double-Stranded | 1 | 2021 | 51 | 0.690 |
Why?
| | Introns | 1 | 2021 | 256 | 0.650 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 19 | 0.640 |
Why?
| | Receptors, Immunologic | 1 | 2021 | 209 | 0.630 |
Why?
| | Testosterone | 1 | 2024 | 416 | 0.630 |
Why?
| | Th17 Cells | 1 | 2020 | 102 | 0.590 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2020 | 194 | 0.560 |
Why?
| | Interferon-beta | 1 | 2019 | 92 | 0.550 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 693 | 0.510 |
Why?
| | Biosensing Techniques | 1 | 2019 | 142 | 0.500 |
Why?
| | Histones | 1 | 2022 | 666 | 0.490 |
Why?
| | Protein Biosynthesis | 1 | 2019 | 452 | 0.460 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 3 | 2025 | 100 | 0.440 |
Why?
| | HIV-1 | 3 | 2026 | 908 | 0.420 |
Why?
| | Cell Differentiation | 1 | 2020 | 2050 | 0.360 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2026 | 1146 | 0.290 |
Why?
| | Virus Latency | 2 | 2026 | 90 | 0.270 |
Why?
| | Immunity, Innate | 3 | 2022 | 835 | 0.260 |
Why?
| | HIV Infections | 3 | 2026 | 3195 | 0.220 |
Why?
| | Platelet Aggregation | 1 | 2025 | 99 | 0.220 |
Why?
| | Cryopreservation | 1 | 2025 | 113 | 0.210 |
Why?
| | Paraparesis, Tropical Spastic | 1 | 2024 | 4 | 0.210 |
Why?
| | Human T-lymphotropic virus 1 | 1 | 2024 | 32 | 0.200 |
Why?
| | HeLa Cells | 3 | 2021 | 632 | 0.200 |
Why?
| | Hemostasis | 1 | 2024 | 98 | 0.200 |
Why?
| | Hemostatics | 1 | 2023 | 64 | 0.190 |
Why?
| | HIV Seropositivity | 1 | 2023 | 119 | 0.190 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 19 | 0.170 |
Why?
| | Bacterial Toxins | 1 | 2022 | 108 | 0.170 |
Why?
| | Glycolysis | 2 | 2020 | 340 | 0.170 |
Why?
| | Clostridium Infections | 1 | 2022 | 74 | 0.170 |
Why?
| | Herpes Simplex Virus Vaccines | 1 | 2020 | 4 | 0.170 |
Why?
| | Phenotype | 2 | 2024 | 3170 | 0.160 |
Why?
| | Smad2 Protein | 1 | 2020 | 37 | 0.160 |
Why?
| | Interleukins | 2 | 2019 | 248 | 0.160 |
Why?
| | Vaccines, Attenuated | 1 | 2020 | 129 | 0.160 |
Why?
| | T-Lymphocyte Subsets | 1 | 2022 | 420 | 0.150 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 98 | 0.150 |
Why?
| | Herpes Simplex | 1 | 2020 | 99 | 0.150 |
Why?
| | Herpesvirus 1, Human | 1 | 2020 | 84 | 0.150 |
Why?
| | RNA, Viral | 2 | 2021 | 692 | 0.150 |
Why?
| | Intestinal Mucosa | 1 | 2025 | 675 | 0.150 |
Why?
| | STAT3 Transcription Factor | 1 | 2020 | 206 | 0.140 |
Why?
| | Vaccines, Subunit | 1 | 2018 | 53 | 0.140 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2019 | 145 | 0.140 |
Why?
| | Antibodies, Neutralizing | 1 | 2020 | 340 | 0.130 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 563 | 0.130 |
Why?
| | Signal Transduction | 2 | 2021 | 5223 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2020 | 673 | 0.120 |
Why?
| | Humans | 16 | 2026 | 145763 | 0.120 |
Why?
| | RNA Stability | 2 | 2015 | 107 | 0.120 |
Why?
| | Cell Line, Tumor | 2 | 2021 | 3551 | 0.120 |
Why?
| | Protein Conformation | 1 | 2019 | 938 | 0.110 |
Why?
| | Gene Expression | 1 | 2020 | 1478 | 0.110 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 5992 | 0.110 |
Why?
| | T-Lymphocytes | 2 | 2022 | 1997 | 0.100 |
Why?
| | RNA Cleavage | 1 | 2014 | 10 | 0.100 |
Why?
| | Models, Molecular | 1 | 2019 | 1599 | 0.100 |
Why?
| | Cell Line | 1 | 2019 | 2823 | 0.100 |
Why?
| | Interferon Type I | 1 | 2014 | 147 | 0.090 |
Why?
| | Protein Binding | 1 | 2019 | 2240 | 0.090 |
Why?
| | Methylmercury Compounds | 1 | 2011 | 9 | 0.090 |
Why?
| | Female | 7 | 2025 | 79035 | 0.080 |
Why?
| | Male | 6 | 2025 | 73003 | 0.080 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2011 | 96 | 0.080 |
Why?
| | Lymphocyte Activation | 2 | 2025 | 1133 | 0.080 |
Why?
| | MicroRNAs | 1 | 2015 | 686 | 0.070 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 308 | 0.070 |
Why?
| | Transcriptome | 1 | 2015 | 1042 | 0.070 |
Why?
| | Glutamic Acid | 1 | 2011 | 255 | 0.070 |
Why?
| | Mice, Transgenic | 3 | 2020 | 2191 | 0.070 |
Why?
| | Mice | 3 | 2020 | 18355 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2026 | 923 | 0.060 |
Why?
| | Neoplasms | 1 | 2022 | 2913 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2601 | 0.060 |
Why?
| | Animals | 5 | 2020 | 38097 | 0.060 |
Why?
| | Middle Aged | 2 | 2025 | 36302 | 0.060 |
Why?
| | Adult | 2 | 2025 | 40872 | 0.050 |
Why?
| | Cold Temperature | 1 | 2025 | 206 | 0.050 |
Why?
| | Alendronate | 1 | 2023 | 14 | 0.050 |
Why?
| | Mycophenolic Acid | 1 | 2024 | 119 | 0.050 |
Why?
| | DNA, Viral | 1 | 2025 | 356 | 0.050 |
Why?
| | Virus Activation | 1 | 2023 | 94 | 0.050 |
Why?
| | Thrombin | 1 | 2023 | 172 | 0.050 |
Why?
| | Purines | 1 | 2023 | 187 | 0.050 |
Why?
| | Virus Replication | 1 | 2025 | 521 | 0.050 |
Why?
| | Interferon-gamma | 1 | 2025 | 784 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2024 | 574 | 0.040 |
Why?
| | Antigens | 1 | 2022 | 348 | 0.040 |
Why?
| | Trigeminal Ganglion | 1 | 2020 | 27 | 0.040 |
Why?
| | Lymphocytes | 1 | 2022 | 376 | 0.040 |
Why?
| | Cornea | 1 | 2020 | 154 | 0.040 |
Why?
| | Aerobiosis | 1 | 2018 | 18 | 0.040 |
Why?
| | Immunization | 1 | 2020 | 375 | 0.040 |
Why?
| | Vaccinia | 1 | 2018 | 20 | 0.040 |
Why?
| | Ovalbumin | 1 | 2018 | 194 | 0.030 |
Why?
| | Interleukin-15 | 1 | 2018 | 95 | 0.030 |
Why?
| | Macrophages | 1 | 2026 | 1507 | 0.030 |
Why?
| | Orthomyxoviridae Infections | 1 | 2018 | 71 | 0.030 |
Why?
| | Immunotherapy | 1 | 2022 | 667 | 0.030 |
Why?
| | Adjuvants, Immunologic | 1 | 2018 | 244 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2020 | 674 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 769 | 0.030 |
Why?
| | Allergens | 1 | 2018 | 386 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2022 | 968 | 0.030 |
Why?
| | Cytokines | 1 | 2022 | 2069 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2015 | 451 | 0.030 |
Why?
| | Hepatitis B virus | 1 | 2014 | 33 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 979 | 0.020 |
Why?
| | Blotting, Western | 1 | 2015 | 1184 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2014 | 205 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2014 | 486 | 0.020 |
Why?
| | Vaccination | 1 | 2020 | 1428 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 855 | 0.020 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2011 | 42 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2883 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 3130 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2015 | 2514 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4151 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2805 | 0.020 |
Why?
| | Mutation | 1 | 2015 | 4090 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2011 | 2399 | 0.010 |
Why?
|
|
Chitrakar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|